BR9811161A - Uso de um ou vários polipeptìdeos ou glicopeptìdeos purificados, provenientes da proteìna e, pre m, ns1, ns3, ou ns5, de diferentes sorotipos de flaviviridiae, notadamente da dengue, kit diagnóstico, e, antìgeno purificado especìfico de flaviviridiae - Google Patents

Uso de um ou vários polipeptìdeos ou glicopeptìdeos purificados, provenientes da proteìna e, pre m, ns1, ns3, ou ns5, de diferentes sorotipos de flaviviridiae, notadamente da dengue, kit diagnóstico, e, antìgeno purificado especìfico de flaviviridiae

Info

Publication number
BR9811161A
BR9811161A BR9811161-2A BR9811161A BR9811161A BR 9811161 A BR9811161 A BR 9811161A BR 9811161 A BR9811161 A BR 9811161A BR 9811161 A BR9811161 A BR 9811161A
Authority
BR
Brazil
Prior art keywords
flaviviridiae
protein
dengue
purified
notably
Prior art date
Application number
BR9811161-2A
Other languages
English (en)
Inventor
Vicent Deubel
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of BR9811161A publication Critical patent/BR9811161A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"USO DE UM OU VáRIOS POLIPEPTìDEOS OU GLICOPEPTìDEOS PURIFICADOS, PROVENIENTES DA PROTEìNA E, PRE M, NS~ 1~, NS~ 3~, OU NS5, DE DIFERENTES SOROTIPOS DE FLAVIVIRIDIAE, NOTADAMENTE DA DENGUE, KIT DIAGNóSTICO, E, ANTìGENO PURIFICADO ESPECìFICO DE FLAVIVIRIDIAE". A invenção refere-se ao uso de um ou vários polipeptídeos ou glicopeptídeos provenientes de proteína E, pre M, NS~ 1~, NS~ 3~ ou NS~ 5~, de diferentes sorotipos de flaviviridiae, notadamente da dengue, e tendo ou não em sua extremidade carboxila um resíduo de 2 a 8 aminoácidos, escolhidos dentre a histidina, triptofano ou cisteína para a fabricação de um kit diagnóstico rápido da determinação do sorotipo incriminado em uma infecção pelo vírus da dengue, e à natureza primária ou secundária da referida infecção específica dos flaviviridiae compreendendo um polipeptídeo ou glicopeptídeo eventualmente marcado proveniente da proteína E, pre M, NS~ 1~, NS~ 3~ ou NS~ 5~, de um vírus da família dos flaviviridiae, e dos anti-IgG, anti-IgM ou anti-IgA seja não marcados, seja marcados ou modificados.
BR9811161-2A 1997-08-14 1998-07-13 Uso de um ou vários polipeptìdeos ou glicopeptìdeos purificados, provenientes da proteìna e, pre m, ns1, ns3, ou ns5, de diferentes sorotipos de flaviviridiae, notadamente da dengue, kit diagnóstico, e, antìgeno purificado especìfico de flaviviridiae BR9811161A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9710403A FR2767324B1 (fr) 1997-08-14 1997-08-14 Utilisation de proteines d'enveloppe recombinantes pour le diagnostic du virus de la dengue
PCT/FR1998/001537 WO1999009414A1 (fr) 1997-08-14 1998-07-13 Utilisation de proteines d'enveloppe recombinantes pour le diagnostic du virus de la dengue

Publications (1)

Publication Number Publication Date
BR9811161A true BR9811161A (pt) 2000-07-25

Family

ID=9510322

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811161-2A BR9811161A (pt) 1997-08-14 1998-07-13 Uso de um ou vários polipeptìdeos ou glicopeptìdeos purificados, provenientes da proteìna e, pre m, ns1, ns3, ou ns5, de diferentes sorotipos de flaviviridiae, notadamente da dengue, kit diagnóstico, e, antìgeno purificado especìfico de flaviviridiae

Country Status (4)

Country Link
AU (1) AU8735798A (pt)
BR (1) BR9811161A (pt)
FR (1) FR2767324B1 (pt)
WO (1) WO1999009414A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005014627A1 (en) * 2003-08-07 2005-02-17 International Centre For Genetic Engineering And Biotechnology Recombinant dengue multi epitope proteins as diagnostic intermediates
WO2005045439A1 (en) * 2003-11-07 2005-05-19 Hepgenics Pty Ltd Binding assay components
AU2004287894B2 (en) * 2003-11-07 2009-01-29 Hepgenics Pty Ltd Binding assay components
SG139546A1 (en) * 2004-07-22 2008-02-29 Nat Environment Agency Diagnostic test
WO2007034507A2 (en) * 2005-09-20 2007-03-29 International Centre For Genetic Engineering And Biotechnology Tetravalent dengue specific domain iii based chimeric recombinant protein
SG135990A1 (en) * 2006-03-16 2007-10-29 Nat Environment Agency Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody
SG137711A1 (en) * 2006-05-11 2007-12-28 Nat Environment Agency Antigen capture anti-dengue iga elisa (aca-elisa) for the detection of a flavivirus specific antibody
SG157244A1 (en) * 2008-05-15 2009-12-29 Mp Biomedicals Asia Pacific Pte Ltd Point of care test for the detection of exposure or immunity to dengue virus
SG10201404571PA (en) * 2014-08-01 2016-03-30 Mp Biomedicals Asia Pacific Pte Ltd Method and kit for detecting a dengue virus infection
MX2023004087A (es) * 2020-10-07 2023-09-15 Sanofi Pasteur Pruebas diagnósticas mejoradas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665710A1 (fr) * 1990-08-10 1992-02-14 Pasteur Institut Baculovirus recombinant exprimant les proteines e et ns1 de virus appartenant aux flaviviridae ou de virus apparentes aux flaviviridae, applications diagnostiques et therapeutiques.
GB9209243D0 (en) * 1992-04-29 1992-06-17 Univ Singapore Dengue virus
JPH07265093A (ja) * 1994-03-30 1995-10-17 Chemo Sero Therapeut Res Inst 哺乳動物細胞を用いる日本脳炎ウイルス表面抗原蛋白質の製法
ATE227584T1 (de) * 1995-05-24 2002-11-15 Hawaii Biotech Group Untereinheitsimpfstoff gegen flavivirus infektion
FR2741077B1 (fr) * 1995-11-14 1998-01-23 Pasteur Institut Vaccin polyvalent anti-dengue
DE19613253A1 (de) * 1996-04-02 1997-10-09 Immuno Gmbh Technik zum Nachweis von Infektionen mit dem TBE-Virus und anderen Flaviviren

Also Published As

Publication number Publication date
FR2767324A1 (fr) 1999-02-19
AU8735798A (en) 1999-03-08
FR2767324B1 (fr) 2001-04-06
WO1999009414A1 (fr) 1999-02-25

Similar Documents

Publication Publication Date Title
BR9811161A (pt) Uso de um ou vários polipeptìdeos ou glicopeptìdeos purificados, provenientes da proteìna e, pre m, ns1, ns3, ou ns5, de diferentes sorotipos de flaviviridiae, notadamente da dengue, kit diagnóstico, e, antìgeno purificado especìfico de flaviviridiae
BR0112602A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
DK0996459T3 (da) Anvendelse af exendiner og agonister deraf til reduktion af födeindtagelse
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
BRPI0011369B8 (pt) método de detecção precoce e kit de diagnóstico precoce de uma infecção flaviviral, processo de purificação da proteína ns1 de um flavivírus,composição imunogênca,utilização da proteína ns1,de pelo menos um anticorpo monoclonal anti-ns1 e da proteína ns1 de forma hexamérica,e, processo de expressão de um polinucleotídeo codificado para a proteína ns1 de um vírus da dengue
ES2109982T3 (es) Procedimiento y composiciones de ensayo para determinar proteasas en suero, particularmente proteina c activada.
NO20003526D0 (no) Proteiner kodet av polynukleinsyrer fra svinereproduktive- og respiratoriske syndromvirus (PRRSV)
DK228190D0 (da) Rajgraespollenallergen
KR910019641A (ko) 사람 유두종 바이러스(hpv) 18의 단백질상의 혈청 반응성 에피토프
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
EP0696640A3 (de) Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
AR033832A1 (es) Un metodo ex vivo para diagnosticar una enfermedad autoinmune, anticuerpo, composicion de diagnostico que lo comprende, y usos del anticuerpo
WO2004016586A3 (en) Compositions and methods related to flavivirus envelope protein domain iii antigens
EP0379549A4 (en) Endotoxin binding protein and uses thereof
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ES2136653T3 (es) Polipeptidos de sintesis pertenecientes al virus de la hepatitis c (vhc) y utilizables principalmente para detectar este ultimo.
FI913714A (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
BRPI0208124B8 (pt) uso de um anticorpo igy imunologicamente específico para a proteína paa associada à virulência de escherichia coli de ligação e eliminação (aeec)
PT704528E (pt) Capsides e proteinas recombinantes do virus da doenca hemorragica dos coelhos ("rhdv"), estojos ("kits") de diagnostico e vacinas que as incluem
KR930004328A (ko) 비-a, 비-b형 펩티드
KR920018075A (ko) 비-a, 비-b형 간염 비루스에 대해 생성된 항체와 면역화학적으로 반응하는 펩티드
BR9909308A (pt) Peptìdeo, ensaio para o diagnóstico de esquizofrenia em um indivìduo, e, kit para uso no diagnóstico de esquizofrenia
BRPI0204599B8 (pt) kit para a detecção simultânea de anticorpo para hcv e antígeno de hcv
Sällberg et al. Passive adsorption of immunologically active and inactive synthetic peptides to polystyrene is influenced by the proportion of non-polar residues in the peptide
Poon et al. On the masking of signals on immunoblots by cellular proteins

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired